Monday, June 1, 2020

Research News

Summaries of research findings that tell of a scientific need to "rethink psychiatry."

Hallucination in the General Population

Investigating the prevalence and types of hallucination-like experiences (HLEs) in a sample of 437 young adults, researchers in Italy, Belgium, the U.K. and Denmark found...

AstraZeneca Wins Seroquel XR Patent Protection

A U.S. district court ruled in favor of AstraZeneca's patent protection for Seroquel XR, the long-acting version of Seroquel. This follows AstraZeneca's failure to...

Antipsychotics Increase Risk of Heart Attack in the Elderly

In a study of 10,969 older patients treated with antipsychotics in Quebec, Canada, researchers found a 2.19 times greater risk of heart attack in...

Placebos In The News

A study that will appear in European Neuropsychopharmacology found that "the brain's response to the placebo pill seems to depend ... on whether or not...

Antidepressants, Not Depression, Raise Risk of Preeclampsia in Pregnancy

In a study of 69,448 pregnant women with depression, researchers from the Harvard school of public health found that use of SSRI (selective serotonin...

Auditory Hallucinations – Expectation, Interpretation, and Emotion

Researchers in Australia, the U.K., the Netherlands, Canada and Belgium reviewed research on auditory hallucinations (AH) in schizophrenia as well other clinical and nonclinical...

FDA Adds Warnings to Celexa’s Label

Following up on last August's warning that high doses of Celexa can cause potentially fatal heart rhythm abnormalities, the FDA has added clarification to...

J&J Tries, Fails to Squeeze Whistle Blower in Texas Risperdal Case

In giving final approval to the $158 million settlement with Texas over illegal promotion of Risperdal, Judge John Dietz denied Johnson &Johnson's request to...

Arkansas Alleges Risperdal Causes Deaths in the Elderly and Lactation in Young Boys

In opening statements in its lawsuit against Johnson & Johnson for lying about Risperdal's risks and promoting its use for unapproved treatments, Arkansas' lawyer...

Second-Generation Antipsychotics Just as Likely as Older Drugs to Cause EPS

In a study of an earlier randomized controlled trial of antipsychotics, researchers from Yale and the U.K found that second-generation antipsychotics were as likely...

AztraZeneca Struggling as Generic Seroquel Gets the Green Light

With a U.S. judge refusing to grant an injunction against generic versions of it's top-selling drug Seroquel last Friday, the Wall Street Journal reports...

Psychiatric Drugs, Especially Antipsychotics, Contribute to Increasing Drug Costs

Antipsychotics have overtaken antidepressants as the most costly class of psychiatric medication in England, according to a study by Stephen Ilyas and Joanna Moncrieff...

Arkansas’ $1.25 Billion Risperdal Trial Starts Today

Arkansas' lawsuit against Johnson & Johnson for false and misleading claims regarding Risperdal is set to begin today, the fourth time J&J has a...

Pharmas Exiting Antidepressant Market

As patents expire on current antidepressants pharmaceutical companies are getting out of the market, according to an article in yesterday's Vancouver Sun. In the latest...

Rejecting Illness as Chronic Contributes to Better Outcomes

Swiss researchers investigated the paradox that both low and high levels of "insight" are a risk factor for poor outcomes such as depression, hopelessness,...

Hypertension in Pregnancy 50% More Likely With SSRIs

Researchers in Montreal found in a sample of 1,216 pregnant women that those who used antidepressants were at least 50% more likely to experience...

Recovery-Oriented Services Benefit Providers As Well

In a study of 114 case managers in Ohio, researchers from Bowling Green State University found that those working at a recovery-oriented center reported...

Living Alone Nearly Doubles Antidepressant Use

Finnish researchers found that in a study of 3471 men and women, those living alone were almost twice as likely to use an antidepressant....

Pharmaceutical Trial Database Mysteriously Disappears

The Public Library of Science (PLoS) revealed today that the lead author of a study identifying publication bias (released this week in PLoS Medicine) has...

Publication Bias in Antipsychotic Trials

Researchers in Oregon looked for discrepancies between published and unpublished FDA-registered trials. They found that four of the 24 FDA-registered trials of second-generation antipsychotics identified...

Mindfulness Decreases Depression & Anxiety, Increases Hope

In a sample of 56 participants who met criteria for a mood disorder, anxiety disorder, and/or substance dependence, researcher from the Emory School of...

Spontaneous Improvement in Depression, With and Without Placebo

Researchers at Columbia University and Queens College reviewed 10 trials of antidepressants that used wait-listed controls in order to determine the contribution of spontaneous...

Contribution of Antipsychotics to Suicidality and Depression

Peter Lehmann reviews the contribution of antipsychotics to suicide and depression in schizophrenia in the current International Journal of Psychotherapy.  Publications about the intrinsic effects of...

Seroquel Abuse Rising, Along With Ambulance Calls

Australian researchers have uncovered an alarming increase of Seroquel-related ambulances calls. Rising prescriptions of of the drug along with its developing use as a drug...

International Society Removes “Schizophrenia” From Its Name

Calling "schizophrenia" an unscientific and stigmatizing construct - with little or no reliability or validity - that implies people with the diagnosis have an irreversible brain...

Follow Us

19,639FansLike
11,994FollowersFollow
3,820SubscribersSubscribe